EPHA2 and neoplasm: To investigate the clinical significance of USP5/EphA2 axis, we used IHC to detect expression levels of USP5 and EphA2 in 119 tumor tissues from patients with NPC, who received radical radiotherapy and concurrent chemotherapy according to a uniform guideline.